Capital World Investors 13D and 13G filings for Allogene Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 7:06 pm Sale | 2025-09-30 | 13G | Allogene Therapeutics, Inc. ALLO | Capital World Investors | 0 0.000% | -12,265,330 (Position Closed) | Filing |
| 2025-05-13 11:44 am Purchase | 2025-03-31 | 13G | Allogene Therapeutics, Inc. ALLO | Capital World Investors | 12,265,330 5.600% | 12,265,330 (New Position) | Filing |